1. 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 – LBA, biomarkers and immunogenicity). (November 2016) Authors: Richards, Susan; Amaravadi, Lakshmi; Pillutla, Renuka; Birnboeck, Herbert; Torri, Albert; Cowan, Kyra J.; Papadimitriou, Apollon; Garofolo, Fabio; Satterwhite, Christina; Piccoli, Steven; Wu, Bonnie; Krinos-Fiorotti, Corinna; Allinson, John; Berisha, Flora; Cocea, Laurent; Croft, Stephanie; Frase... Journal: Bioanalysis Issue: Volume 8:Number 23(2016) Page Start: 2475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab‐associated progressive multifocal leukoencephalopathy. Issue 6 (24th October 2014) Authors: Plavina, Tatiana; Subramanyam, Meena; Bloomgren, Gary; Richman, Sandra; Pace, Amy; Lee, Sophia; Schlain, Brian; Campagnolo, Denise; Belachew, Shibeshih; Ticho, Barry Journal: Annals of neurology Issue: Volume 76:Issue 6(2014:Dec.) Page Start: 802 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Changes to anti-JCV antibody levels in a Swedish national MS cohort. Issue 11 (5th March 2013) Authors: Warnke, Clemens; Ramanujam, Ryan; Plavina, Tatiana; Bergström, Tomas; Goelz, Susan; Subramanyam, Meena; Kockum, Ingrid; Rahbar, Afsar; Kieseier, Bernd C; Holmén, Carolina; Olsson, Tomas; Hillert, Jan; Fogdell-Hahn, Anna Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 84:Issue 11(2013) Page Start: 1199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical development of biosimilars: an evolving landscape. (March 2013) Authors: Subramanyam, Meena Journal: Bioanalysis Issue: Volume 5:Number 5(2013) Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a. (November 2015) Authors: White, Joleen T; Crossman, Mary; Richter, Kelly; Berman, Melissa; Goyal, Jaya; Subramanyam, Meena Journal: Bioanalysis Issue: Volume 7:Number 21(2015) Page Start: 2801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial. (July 2016) Authors: White, Joleen T.; Newsome, Scott D.; Kieseier, Bernd C.; Bermel, Robert A.; Cui, Yue; Seddighzadeh, Ali; Hung, Serena; Crossman, Mary; Subramanyam, Meena Journal: Therapeutic advances in neurological disorders Issue: Volume 9:Number 4(2016:Jul.) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Incurred sample reproducibility and stability assessment in a cell-based drug concentration assay. (June 2015) Authors: White, Joleen T; Crossman, Mary; Subramanyam, Meena Journal: Bioanalysis Issue: Volume 7:Number 11(2015) Page Start: 1347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Incurred sample reproducibility and stability assessment in a cell-based drug concentration assay. (June 2015) Authors: White, Joleen T; Crossman, Mary; Subramanyam, Meena Journal: Bioanalysis Issue: Volume 7:Number 11(2015) Page Start: 1347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Population Pharmacokinetics and Target Engagement of Natalizumab in Patients With Multiple Sclerosis. (11th April 2017) Authors: Muralidharan, Kumar Kandadi; Kuesters, Geoffrey; Plavina, Tatiana; Subramanyam, Meena; Mikol, Daniel D.; Gopal, Sreeja; Nestorov, Ivan Journal: Journal of clinical pharmacology Issue: Volume 57:Number 8(2017) Page Start: 1017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients. (10th October 2017) Authors: Plavina, Tatiana; Muralidharan, Kumar Kandadi; Kuesters, Geoffrey; Mikol, Daniel; Evans, Karleyton; Subramanyam, Meena; Nestorov, Ivan; Chen, Yi; Dong, Qunming; Ho, Pei-Ran; Amarante, Diogo; Adams, Alison; De Sèze, Jerome; Fox, Robert; Gold, Ralf; Jeffery, Douglas; Kappos, Ludwig; Montalban, Xavi... Journal: Neurology Issue: Volume 89:Number 15(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗